Cargando…
Formoterol in the management of chronic obstructive pulmonary disease
Bronchodilators represent the hallmark of symptomatic treatment of Chronic Obstructive Pulmonary Disease (COPD). There are four categories of bronchodilators: anticholinergics, methylxanthines, short-acting β(2)-agonists, and long-acting β(2)-agonists such as formoterol. Significant research has bee...
Autores principales: | Steiropoulos, Paschalis, Tzouvelekis, Argyris, Bouros, Demosthenes |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629967/ https://www.ncbi.nlm.nih.gov/pubmed/18686730 |
Ejemplares similares
-
Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012) -
HbA(1c) is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men
por: Papanas, Nikolaos, et al.
Publicado: (2009) -
Application of microarray technology in pulmonary diseases
por: Tzouvelekis, Argyris, et al.
Publicado: (2004) -
Predictors of obstructive sleep apnea in males with metabolic syndrome
por: Papanas, Nikolaos, et al.
Publicado: (2010) -
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2011)